InvestorsHub Logo
Followers 19
Posts 1896
Boards Moderated 0
Alias Born 02/10/2014

Re: None

Monday, 06/08/2015 10:15:54 PM

Monday, June 08, 2015 10:15:54 PM

Post# of 8334
This was a $15 stock that failed its primary endpoint in 2014. But, the FDA accepted the end points obtained for the phase 3. It's literally a $15 stock at a 50% discount. Who wouldn't play the obvious gap? I certainly am.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TNXP News